Breakthrough
SubstackBreakthrough is a Substack newsletter by a medicine researcher that analyses frontier drug development, such as ESMO trial novelty rankings, 2026 first-in-class approvals, and first-in-human trials in China. It offers readers a structured, data-driven overview of where cutting-edge therapeutics are heading.